Sun Z F, Larsen C T, Huang F F, Billam P, Pierson F W, Toth T E, Meng X J
Center for Molecular Medicine and Infectious Diseases, College of Veterinary Medicine, Virginia Polytechnic Institute and State University, 1410 Price's Fork Rd., Blacksburg, VA 24061-0342, USA.
J Clin Microbiol. 2004 Jun;42(6):2658-62. doi: 10.1128/JCM.42.6.2658-2662.2004.
Avian hepatitis E virus (HEV), a novel virus identified from chickens with hepatitis-splenomegaly syndrome in the United States, is genetically and antigenically related to human HEV. In order to further characterize avian HEV, an infectious viral stock with a known infectious titer must be generated, as HEV cannot be propagated in vitro. Bile and feces collected from specific-pathogen-free (SPF) chickens experimentally infected with avian HEV were used to prepare an avian HEV infectious stock as a 10% suspension of positive fecal and bile samples in phosphate-buffered saline. The infectivity titer of this infectious stock was determined by inoculating 1-week-old SPF chickens intravenously with 200 microl of each of serial 10-fold dilutions (10(-2) to 10(-6)) of the avian HEV stock (two chickens were inoculated with each dilution). All chickens inoculated with the 10(-2) to 10(-4) dilutions of the infectious stock and one of the two chickens inoculated with the 10(-5) dilution, but neither of the chickens inoculated with the 10(-6) dilution, became seropositive for anti-avian HEV antibody at 4 weeks postinoculation (wpi). Two serologically negative contact control chickens housed together with chickens inoculated with the 10(-2) dilution also seroconverted at 8 wpi. Viremia and shedding of virus in feces were variable in chickens inoculated with the 10(-2) to 10(-5) dilutions but were not detectable in those inoculated with the 10(-6) dilution. The infectivity titer of the infectious avian HEV stock was determined to be 5 x 10(5) 50% chicken infectious doses (CID(50)) per ml. Eight 1-week-old turkeys were intravenously inoculated with 10(5) CID(50) of avian HEV, and another group of nine turkeys were not inoculated and were used as controls. The inoculated turkeys seroconverted at 4 to 8 wpi. In the inoculated turkeys, viremia was detected at 2 to 6 wpi and shedding of virus in feces was detected at 4 to 7 wpi. A serologically negative contact control turkey housed together with the inoculated ones also became infected through direct contact. This is the first demonstration of cross-species infection by avian HEV.
禽戊型肝炎病毒(HEV)是一种从美国患有肝炎-脾肿大综合征的鸡中鉴定出的新型病毒,在基因和抗原方面与人类HEV相关。为了进一步表征禽HEV,由于HEV无法在体外培养,必须制备具有已知感染滴度的感染性病毒储备液。从经实验感染禽HEV的无特定病原体(SPF)鸡收集的胆汁和粪便用于制备禽HEV感染性储备液,方法是将阳性粪便和胆汁样品以10%的比例悬浮于磷酸盐缓冲盐水中。通过给1周龄的SPF鸡静脉注射200微升禽HEV储备液的系列10倍稀释液(10⁻²至10⁻⁶)中的每一种(每种稀释液接种两只鸡)来测定该感染性储备液的感染滴度。接种了感染性储备液10⁻²至10⁻⁴稀释液的所有鸡以及接种10⁻⁵稀释液的两只鸡中的一只,在接种后4周(wpi)时抗禽HEV抗体呈血清阳性,但接种10⁻⁶稀释液的两只鸡均未出现这种情况。与接种10⁻²稀释液的鸡饲养在一起的两只血清学阴性接触对照鸡在8 wpi时也发生了血清转化。接种10⁻²至10⁻⁵稀释液的鸡的病毒血症和粪便中病毒排出情况各不相同,但接种10⁻⁶稀释液的鸡中未检测到。禽HEV感染性储备液的感染滴度测定为每毫升5×10⁵ 50%鸡感染剂量(CID₅₀)。八只1周龄的火鸡静脉接种10⁵ CID₅₀的禽HEV,另一组九只火鸡未接种作为对照。接种的火鸡在4至8 wpi时发生血清转化。在接种的火鸡中,在2至6 wpi时检测到病毒血症,在4至7 wpi时检测到粪便中病毒排出。与接种的火鸡饲养在一起的一只血清学阴性接触对照火鸡也通过直接接触而被感染。这是禽HEV跨物种感染的首次证明。